Get the Stockscreener App
122.04
0.35%
0.42
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Teleflex Incorporated stock is traded at $122.04, with a volume of 400.31K.
It is up +0.35% in the last 24 hours and up +6.66% over the past month.
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.
See More
Previous Close:
$121.62
Open:
$121.01
24h Volume:
400.31K
Relative Volume:
0.64
Market Cap:
$5.39B
Revenue:
$3.04B
Net Income/Loss:
$191.94M
P/E Ratio:
28.73
EPS:
4.2479
Net Cash Flow:
$396.44M
1W Performance:
-0.24%
1M Performance:
+6.66%
6M Performance:
+3.11%
1Y Performance:
-31.43%
1-Day Range:
$120.31
$122.25
1-Week Range:
$120.31
$123.55
52-Week Range:
$102.58
$185.94
Teleflex Incorporated Stock (TFX) Company Profile
Name
Teleflex Incorporated
Sector
Industry
Phone
610-225-6800
Address
550 E SWEDESFORD RD, WAYNE, PA
Compare TFX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TFX
Teleflex Incorporated
|
122.04 | 5.37B | 3.04B | 191.94M | 396.44M | 4.2479 |
|
ISRG
Intuitive Surgical Inc
|
566.36 | 203.00B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
194.07 | 55.74B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
78.81 | 38.96B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
240.87 | 35.48B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
42.00 | 33.00B | 27.43B | 1.27B | 1.01B | 1.5829 |
Teleflex Incorporated Stock (TFX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-04-25 | Downgrade | BofA Securities | Neutral → Underperform |
| Feb-28-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Feb-28-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Feb-28-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Feb-27-25 | Downgrade | Citizens JMP | Mkt Outperform → Mkt Perform |
| Jul-01-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-04-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jun-21-23 | Downgrade | Needham | Buy → Hold |
| May-30-23 | Initiated | CL King | Buy |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Apr-26-23 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Oct-26-22 | Initiated | Mizuho | Neutral |
| Oct-14-22 | Resumed | Stephens | Overweight |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jul-29-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-06-22 | Initiated | Wolfe Research | Outperform |
| May-09-22 | Initiated | BofA Securities | Neutral |
| Apr-13-22 | Initiated | Truist | Hold |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| Oct-07-21 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Sep-07-21 | Resumed | Raymond James | Outperform |
| Jul-19-21 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Jan-06-21 | Reiterated | Needham | Buy |
| Nov-02-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jan-31-20 | Reiterated | Needham | Buy |
| Aug-02-19 | Reiterated | Needham | Buy |
| Jun-11-19 | Initiated | Wells Fargo | Outperform |
| Apr-24-19 | Downgrade | Needham | Strong Buy → Buy |
| Feb-22-19 | Reiterated | Needham | Strong Buy |
| Oct-16-18 | Initiated | Barclays | Equal Weight |
| Sep-10-18 | Upgrade | Needham | Buy → Strong Buy |
| Aug-03-18 | Reiterated | Needham | Buy |
| May-14-18 | Reiterated | Needham | Buy |
| May-04-18 | Reiterated | Needham | Buy |
| Apr-04-18 | Initiated | Goldman | Neutral |
| Nov-10-17 | Resumed | Piper Jaffray | Overweight |
| Nov-03-17 | Reiterated | Needham | Buy |
| Sep-08-17 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| Sep-06-17 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-06-17 | Reiterated | Needham | Buy |
| Mar-07-17 | Initiated | Needham | Buy |
| Jan-06-17 | Upgrade | Jefferies | Hold → Buy |
| Jul-12-16 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
View All
Teleflex Incorporated Stock (TFX) Latest News
Teleflex Announces Divestment of Acute Care, Urology, and OEM Units in $2B Deal - The Healthcare Technology Report.
We Think Teleflex (NYSE:TFX) Can Stay On Top Of Its Debt - 富途牛牛
Teleflex Incorporated (TFX) Stock Price History & Data - Traders Union
Teleflex to Present at the Deutsche Bank 38th Annual Health Care Conference - AOL.com
Teleflex Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Teleflex Inc. stock outperforms competitors on strong trading day - MarketWatch
Is Teleflex Attractively Priced After Sharp Five Year Slide and DCF Concerns in 2025 - Yahoo Finance
Teleflex Incorporated (TFX): A bull case theory - MSN
Teleflex Inc. Stock Underperforms Friday When Compared To Competitors - 富途牛牛
Teleflex (TFX): Reassessing Valuation After Recent Share Price Pullback and Mixed Long-Term Returns - Yahoo Finance
Published on: 2025-12-22 07:50:00 - moha.gov.vn
Wedge Capital Management L L P NC Takes Position in Teleflex Incorporated $TFX - MarketBeat
Will Teleflex Incorporated (TBH) stock sustain bullish trend into 2025Rate Hike & Smart Investment Allocation Insights - Улправда
Raymond James Keeps Their Hold Rating on Teleflex (TFX) - The Globe and Mail
Is Teleflex Incorporated stock undervalued after correctionEarnings Risk Report & Verified Technical Trade Signals - Улправда
What risks investors should watch in Teleflex Incorporated stockEarnings Summary Report & Reliable Trade Execution Plans - Улправда
Teleflex Inc. stock underperforms Friday when compared to competitors - MarketWatch
Will Teleflex Incorporated stock enhance shareholder valueJuly 2025 Summary & Risk Managed Trade Strategies - Улправда
Why retail investors favor Teleflex Incorporated stockJuly 2025 Update & Verified Entry Point Signals - DonanımHaber
How Teleflex Incorporated stock trades pre earnings2025 Dividend Review & AI Forecasted Entry and Exit Points - Bölüm Sonu Canavarı
Will Teleflex Incorporated stock outperform growth indexesJuly 2025 Reactions & Long-Term Safe Investment Plans - DonanımHaber
Is Teleflex Incorporated stock a good choice for value investorsWeekly Stock Summary & AI Powered Market Trend Analysis - DonanımHaber
Why Teleflex Incorporated stock attracts global investorsShort Setup & Weekly Breakout Watchlists - DonanımHaber
What momentum indicators show for Teleflex Incorporated stockJuly 2025 Big Picture & Daily Profit Focused Screening - Улправда
Why Teleflex Incorporated (TBH) stock signals breakout potential2025 Winners & Losers & Safe Entry Point Identification - Улправда
Teleflex Announces FDA Clearance for Expanded Use of QuikClot Control+ Hemostatic Device - MSN
Is Teleflex Incorporated stock cheap by valuation metricsMarket Growth Summary & Safe Capital Allocation Plans - Улправда
Teleflex (TFX) Analyst Ratings Update: Truist Securities Revises Price Target | TFX Stock News - GuruFocus
Truist Securities Adjusts Price Target on Teleflex to $135 From $120, Maintains Hold Rating - marketscreener.com
Coloplast annoncerer ændringer i ledelsesteamet - GlobeNewswire Inc.
Intersurgical Acquires Teleflex Acute Care, Interventional Urology - respiratory-therapy.com
RBC Adjusts Price Target on Teleflex to $135 From $120, Maintains Sector Perform Rating - marketscreener.com
Should You Retain Teleflex Stock in Your Portfolio Now? - WV News
Teleflex Inc. stock outperforms competitors despite losses on the day - MarketWatch
Teleflex strikes $2 billion asset sale, clears path for buybacks and focused growth - MSN
Teleflex Strikes $2 Billion Asset Sale, Clears Path for Buybacks and Focused Growth - MyChesCo
Wayne’s Teleflex to Sell Three Business Divisions in Two Separate Deals - VISTA.Today
Teleflex sells acute care and urology businesses for $2.03 billion - Today's Medical Developments
Teleflex to sell acute care, interventional urology, OEM units for $2.03B - MSN
Teleflex Reports Q1 2025 Results and Revises Full-Year Guidance - MSN
Medtech in a Minute: Teleflex Divestment & More - Medical Device and Diagnostic industry
Teleflex (NYSE:TFX) Shares Rise After Vascular Acquisition News - Kalkine Media
Teleflex Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Wells Fargo Maintains Teleflex (TFX) Equal-Weight Recommendation - Nasdaq
Teleflex: Selling, But How Much? (NYSE:TFX) - Seeking Alpha
Teleflex (TFX) Receives Updated Analyst Rating from Wells Fargo - GuruFocus
Teleflex to sell 3 medical technology divisions for a combined $2B - The Business Journals
Teleflex Sells Acute Care, Urology, and Medtech OEM Businesses in $2B Deal - PlasticsToday
Teleflex inks deals to sell 3 businesses for $2B - MedTech Dive
Teleflex to sell trio of business lines in deals totalling over $2bn - Yahoo Finance
US: Montagu and Kohlberg to carve out Teleflex Medical OEM for US$1.5bn - Investors in Healthcare
Teleflex Incorporated Stock (TFX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.26%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):